La maladie de Parkinson au Canada (serveur d'exploration) - Merge (Accueil)

Index « Auteurs » - entrée « Claude Rouillard »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Claude R. Duguay < Claude Rouillard < Claude Rouleau  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
001587 (2012) Golnasim Riahi [Canada] ; Marc Morissette [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Pershia Samadi [Canada] ; Martin Parent [Canada] ; Thérèse Di Paolo [Canada]Effect of chronic L-DOPA treatment on 5-HT1A receptors in parkinsonian monkey brain
001E66 (2010) Mélanie Bousquet [Canada] ; Claire Gibrat [Canada] ; Mélissa Ouellet [Canada] ; Claude Rouillard [Canada] ; Frédéric Calon [Canada] ; Francesca Cicchetti [Canada]Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases
002285 (2009) Claire Gibrat [Canada] ; Martine Saint-Pierre [Canada] ; Mélanie Bousquet [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Francesca Cicchetti [Canada]Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions
002911 (2007) Daniel Levesque [Canada] ; Claude Rouillard [Canada]Nur77 and retinoid X receptors : crucial factors in dopamine-related neuroadaptation
002A03 (2006) Pershia Samadi [Canada] ; Paul J. Bédard ; Claude RouillardOpioids and motor complications in Parkinson's disease.
002B21 (2006) Michel St-Hilaire [Canada] ; Emmanuelle Bourhis [Canada] ; Daniel Lévesque [Canada] ; Claude Rouillard [Canada]Impaired behavioural and molecular adaptations to dopamine denervation and repeated L‐DOPA treatment in Nur77‐knockout mice
002B38 (2006) Pershia Samadi [Canada] ; Laurent Grégoire [Canada] ; Claude Rouillard [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] ; Daniel Lévesque [Canada]Docosahexaenoic acid reduces levodopa‐induced dyskinesias in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine monkeys
002C35 (2006) Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Claude Rouillard [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] ; Daniel Levesque [Canada]Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys
002D12 (2005) Michel St-Hilaire [Canada] ; Eric Landry ; Daniel Lévesque ; Claude RouillardDenervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
002F10 (2004) Nicolas Lapointe [Canada] ; Michel St-Hilaire ; Maria-Grazia Martinoli ; Julie Blanchet ; Peter Gould ; Claude Rouillard ; Francesca CicchettiRotenone induces non-specific central nervous system and systemic toxicity.
005560 (1988) Claude Rouillard [Canada] ; Paul Bédard [Canada] ; Pierre Falardeau [Canada] ; Thérèse Di Paolo [Canada]Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Claude Rouillard" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "Claude Rouillard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    Claude Rouillard
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022